176 related articles for article (PubMed ID: 34419064)
1. Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study.
Zhao GS; Liu S; Liu Y; Ma J; Wang RY; Bian J; Zhou J; Wu JL; Zhang YW
World J Surg Oncol; 2021 Aug; 19(1):249. PubMed ID: 34419064
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience.
Zhou J; Liu Y; Ren Z; Zhang Y; Zhang M
J Cancer Res Ther; 2017; 13(5):767-772. PubMed ID: 29237901
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma: A Single Center Retrospective Study.
Kamran AU; Liu Y; Li FE; Liu S; Wu JL; Zhang YW
Medicine (Baltimore); 2015 Dec; 94(52):e2154. PubMed ID: 26717358
[TBL] [Abstract][Full Text] [Related]
4. 350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy.
Zhao GS; Li C; Liu Y; Ren ZZ; Yuan XL; Zhou J; Zhang YW; Zhang M
Medicine (Baltimore); 2017 Apr; 96(16):e6629. PubMed ID: 28422858
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of gelatin sponge microparticles-transcatheter arterial chemoembolization combined with synchronous antigen-presenting dendritic cell sequential reinfusion for treatment of advanced large liver cancer: A single-center, prospective, non-randomized, controlled trial.
Zhao GS; Liu S; Liu Y; Li C; Wang RY; Bian J; Zhu RP; Zhou J; Zhang YW
Medicine (Baltimore); 2022 Feb; 101(8):e28803. PubMed ID: 35212274
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
7. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
[TBL] [Abstract][Full Text] [Related]
8. Trans-arterial p53-gene-embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B: single-center experience.
Liu Y; Zhang Y; Bautista D; Tang S; Zhou J; Li C; Zhao G
Cell Biochem Biophys; 2015 Jan; 71(1):99-104. PubMed ID: 25323562
[TBL] [Abstract][Full Text] [Related]
9. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
11. Diaphragmatic weakness after transcatheter arterial chemoembolization of the right inferior phrenic artery for treatment of hepatocellular carcinoma: a comparison of outcomes after N-butyl cyanoacrylate versus gelatin sponge embolization.
Noh SY; Gwon DI; Park S; Yang WJ; Chu HH; Kim JW
Acta Radiol; 2022 Jan; 63(1):48-58. PubMed ID: 33356351
[TBL] [Abstract][Full Text] [Related]
12. Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation.
Ko HK; Ko GY; Yoon HK; Sung KB
Korean J Radiol; 2007; 8(4):320-7. PubMed ID: 17673843
[TBL] [Abstract][Full Text] [Related]
13. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
14. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
[TBL] [Abstract][Full Text] [Related]
17. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma.
Seong J; Keum KC; Han KH; Lee DY; Lee JT; Chon CY; Moon YM; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):393-7. PubMed ID: 10030267
[TBL] [Abstract][Full Text] [Related]
18. Gelatin sponge microparticles for the treatment of the spontaneous rupture of hepatocellular carcinoma hemorrhage.
Wu PZ; Zhou J; Zhang YW
Exp Ther Med; 2016 Oct; 12(4):2201-2207. PubMed ID: 27698712
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of gelatin sponge microparticles in a rabbit VX2 liver tumor model of hepatic arterial chemoembolization.
Zhang YW; Ao J; Liu Y; Qiao MX; Yang XL; Tang SX; Li C; Xu K
Tumour Biol; 2014 Nov; 35(11):10905-10. PubMed ID: 25085588
[TBL] [Abstract][Full Text] [Related]
20. Treatment for liver metastases from breast cancer: results and prognostic factors.
Li XP; Meng ZQ; Guo WJ; Li J
World J Gastroenterol; 2005 Jun; 11(24):3782-7. PubMed ID: 15968739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
